CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy.
about
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryApoptosis and Bcl-2 expression in cultured murine splenic T cellsInterleukin-2 and loss of immunity in experimental Mycobacterium avium infectionOral carriage of Candida albicans in murine AIDS.Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirusEvidence that the murine AIDS defective virus does not encode a superantigen.Endogenous Mtv-encoded superantigens are not required for development of murine AIDS.Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virusModulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania majorSevere immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgeneAntigen-independent changes in naive CD4 T cells with aging.The p15gag and p12gag regions are both necessary for the pathogenicity of the murine AIDS virus.Murine AIDS requires CD154/CD40L expression by the CD4 T cells that mediate retrovirus-induced disease: Is CD4 T cell receptor ligation needed?Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.Immunoregulatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products.Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice.CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection.CD40-deficient mice infected with the defective murine leukemia virus LP-BM5def do not develop murine AIDS but produce IgE and IgG1 in vivo.Unique CD4(+) T cells in TCR alpha chain-deficient class I MHC-restricted TCR transgenic mice: role in a superantigen-mediated disease process.
P2860
Q24804110-3E978F4E-527D-4D55-ABAA-94B4A1D1D9DFQ28586419-49CA29DB-46B1-450C-AF03-318CDA5B1743Q34115948-D4EF9BEF-8313-4154-A87D-5CAA70149147Q35567366-1B4EFCCC-9795-4222-85FA-BE275BBC4C5AQ35840937-1CE04C9B-F60C-4A2A-8A60-F2ED44F3CEEDQ35853091-F6F5C039-090F-42B5-8C43-D7BF814116ADQ35872775-855AC88A-225D-4505-9D14-7F877BE56FC9Q35881027-A075D103-198C-48D5-8A5F-49C3381105C3Q35883083-E875A98A-EBA3-4D27-9F03-39BF96A74056Q36362819-56498794-2766-40D2-9421-692F3E84206EQ36367675-9E9E82FB-3AEA-4C37-B763-BE693EFF29C4Q36634867-876B4620-6B3E-4DF8-B1EC-DC30B3E5B408Q37308258-CF05D880-8DA4-4EA7-B0FD-96522ABE23CDQ39874146-12A2389A-2398-40DD-BFDD-770538BFCDDBQ40903650-F49E3461-EC99-41AD-938B-F5DC4D3987F0Q42808922-FFBADBC3-0CE0-44DF-82D2-0022516A2617Q43225104-E8566AD2-AE53-4AA3-9BF5-8EA52154D261Q45750969-514522B0-F87E-4C22-9765-4BC90B1CD876Q52536193-7CC72113-FB29-4EF2-A202-DA67BEF89244
P2860
CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@ast
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@en
type
label
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@ast
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@en
prefLabel
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@ast
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@en
P2093
P2860
P356
P1476
CD4 T cells in murine acquired ...... yclonal progression to anergy.
@en
P2093
P2860
P304
P356
10.1084/JEM.175.6.1589
P407
P577
1992-06-01T00:00:00Z